Products & Portfolio (2)
BARHEMSYS
amisulpride
Peak
INTRAVENOUS · SOLUTION
Dopamine D2 Antagonists
vomiting (PONV)either alonecombination with an antiemetic of a different class
2020
0
BYFAVO
remimazolam besylate
Peak
INTRAVENOUS · POWDER
benzodiazepine. BYFAVO binds to brain benzodiazepine sites (gamma amino butyric acid type A [GABA A ] receptors), while its carboxylic acid metabolite (CNS7054) has a 300 times lower affinity for the receptor. BYFAVO, like other benzodiazepines, did not show clear selectivity between subtypes of the GABA A receptor.
2020
0
Open Jobs (0)
No open positions listed yet.
Interview Prep Quick Facts
Portfolio: 2 approved products
Top TAs: Psychiatry
Portfolio Health
Peak2 (100%)
2 total products